학술논문
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction
Document Type
Article
Author
Source
In Journal of Advanced Research March 2024
Subject
Language
ISSN
2090-1232